Home
Browse
Search
Latest additions
Policies
FAQ
About Open Access
Browse by Author
Browse by Year
Browsing publications by
Michael Batey
Newcastle Authors
Title
Year
Dr Joanne Munck
Michael Batey
Dr Yan Zhao
Dr Celine Cano
Dr Michele Tavecchio
et al.
Chemosensitisation of cancer cells by KU-0060648; a dual inhibitor of DNA-PK and PI-3K
2012
Michael Batey
Dr Yan Zhao
Dr Helen Maitland
Professor Hing Leung
Professor Andy Hall
et al.
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma
2011
Michael Batey
Dr Andrew Pike
Dr Julie Irving
Professor Herbie Newell
Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models
2011
Patricia Garrido Castro
Dr Simon Bomken
Elda Latif
Michael Batey
Hesta McNeill
et al.
ANGIOPOIETIN1 a Novel Factor Implicated In MLL Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene Dependent Manner
2010
Elda Latif
Michael Batey
Hesta McNeill
Professor Josef Vormoor
Professor Olaf Heidenreich
et al.
ANGIOPOIETIN1-a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner
2010
Henrike Knizia
Michael Batey
Gilberto Almeida
Dr Ross Maxwell
Dr Petra Dildey
et al.
Development of an orthotopic model for human malignant bone diseases in immunocompromised NOD.Cg-Prkdc
scid
Il2rg
tmlwjl/szj
(NSG) mice
2010
Michael Batey
Professor Herbie Newell
Professor Nicola Curtin
Chemosensitisation of cancer cells by KU-0060648, a potent and selective inhibitor of DNA-PK [abstract]
2008
Michael Batey
Dr Amy Peasland
Dr Julie Irving
Professor Herbie Newell
Development of inhibitors of the fibroblast growth factor receptor (FGFR) kinase using a fragment based approach
2008
Michael Batey
Dr Helen Maitland
Professor Hing Leung
Professor Andy Hall
Professor Graham Jackson
et al.
In vitro activity of the multi targeted receptor tyrosine kinase inhibitor sunitinib against multiple myeloma cell lines is not predictive of in vivo xenograft response
2008
Michael Batey
Dr Laurent Rigoreau
Professor Roger Griffin
Professor Herbie Newell
Professor Nicola Curtin
et al.
Potent
in vitro
and
in vivo
radiosensitisation by the selective DNA-dependent protein kinase inhibitor KU-0060648 [abstract]
2008
1
2
3